glp-1 ckd Design and discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis image3.png

Side effects are similar regardless of age: primarily gastrointestinal (nausea, constipation, diarrhea)

The jump from 5 mg to 10 mg is massive: 16.0% to 21.4% body weight reduction

For patients with genetic predispositions to reduced GLP-1 sensitivity, GLP-Squared Injectiona dual compound combining semaglutide and tirzepatideaddresses multiple hunger pathways simultaneously

Manufacturers also dont need to prove they work before selling them

Molecular Formula: C221H342N46O68 Molecular Weight: 4731 g/mol Purity: 99% Further Options Disclaimer: All our products online are only for research, laboratory, or analytical purposes

Extended Data Figure 6 Binding of GLP-1 and exendin-4 (9-39) to representative constructs